PTPRZ1高表达胶质瘤干细胞诱导TAM向M2免疫抑制表型极化的机制研究

安乐乐; 杨莹; 刘庆; 窦飞越; 王路静; 程玥; 王超; 阮潜瑛; 周磊; 郭海涛; 孔维凯; 李学刚; 兰川; 李飞; 时雨

doi:10.16016/j.2097-0927.202401021

您当前的位置：

首页 >

文章列表页 >

PTPRZ1高表达胶质瘤干细胞诱导TAM向M2免疫抑制表型极化的机制研究

基础医学 | 更新时间：2026-01-09

- PTPRZ1高表达胶质瘤干细胞诱导TAM向M2免疫抑制表型极化的机制研究
- Mechanism of glioma stem cells with high expression of PTPRZ1 inducing TAMs polarization to M2 immunosuppressive phenotype
- 陆军军医大学学报 2024年46卷第8期页码：796-803
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学)第一附属医院：病理科
  2.400039 重庆，金凤实验室，渝粤病理科学研究中心
  3.400038 重庆，陆军军医大学(第三军医大学)第一附属医院：输血科
  4.400038 重庆，陆军军医大学(第三军医大学)第一附属医院：神经外科
- 作者简介：
  
  [时雨，E-mail: shiyu@tmmu.edu.cn SHI Yu, E-mail: shiyu@tmmu.edu.cn
- 基金信息：
  
  国家重点研发计划青年科学家项目(2021YFA1103000);国家自然科学基金面上项目(82373191);国家自然科学基金青年基金项目(82102889);重庆市自然科学基金博士后科学基金项目(cstc2021jcyj-bshX0063)
- DOI：10.16016/j.2097-0927.202401021
  中图分类号： R394.3;R730.23;R730.264
- 收稿：2024-01-19，
  
  修回：2024-02-19，
  
  纸质出版：2024-04-30
- 稿件说明：
移动端阅览
安乐乐, 杨莹, 刘庆, 等. PTPRZ1高表达胶质瘤干细胞诱导TAM向M2免疫抑制表型极化的机制研究[J]. 陆军军医大学学报, 2024,46(8):796-803.

Lele AN, Ying YANG, Qing LIU, et al. Mechanism of glioma stem cells with high expression of PTPRZ1 inducing TAMs polarization to M2 immunosuppressive phenotype[J]. Journal of Army Medical University, 2024, 46(8): 796-803.
安乐乐, 杨莹, 刘庆, 等. PTPRZ1高表达胶质瘤干细胞诱导TAM向M2免疫抑制表型极化的机制研究[J]. 陆军军医大学学报, 2024,46(8):796-803. DOI： 10.16016/j.2097-0927.202401021.

Lele AN, Ying YANG, Qing LIU, et al. Mechanism of glioma stem cells with high expression of PTPRZ1 inducing TAMs polarization to M2 immunosuppressive phenotype[J]. Journal of Army Medical University, 2024, 46(8): 796-803. DOI： 10.16016/j.2097-0927.202401021.

摘要

目的

探究蛋白酪氨酸磷酸酶受体Z1型(protein tyrosine phosphatase receptor-type Z1，PTPRZ1)高表达胶质瘤干细胞(glioma stem cells，GSCs)对肿瘤相关巨噬细胞(tumor-associated macrophage，TAM)表型极化和吞噬能力的影响及其调控机制。

方法

利用流式细胞术分选人胶质母细胞瘤(glioblastoma，GBM)样本中GSCs和非干性肿瘤细胞(non-stem tumor cells，NSTCs)，并检测PTPRZ1表达。用胶质瘤细胞条件培养基或趋化因子配体20(chemokine C-C motif ligand 20，CCL20)诱导外周单核细胞(peripheral blood mononuclear cells，PBMC)来源的CD14阳性单核细胞向TAM极化。通过CRISPR/Cas9技术构建PTPRZ1稳定敲除的GSCs细胞株(PTPRZ1-KO GSCs)。利用流式细胞术检测TAM吞噬GSCs、NSTCs、PTPRZ1-Control GSCs(PTPRZ1-Ctrl GSCs)和PTPRZ1-KO GSCs的能力和TAM免疫抑制(M2)表型极化标记物CD163的表达。于基因表达综合数据库(gene expression omnibus

GEO)中配对GSCs和NSTCs转录组测序数据(GSE54791)中获得差异表达基因；于癌症和肿瘤基因图谱(the cancer genome atlas，TCGA)数据库GBM队列中鉴定预后不良基因集。上述基因集与编码人膜蛋白基因集取交集获得PTRRZ1，利用基因集富集分析(gene set enrichment Analysis，GSEA)比较TCGA数据库中高表达和低表达PTPRZ1的GBM样本的差异通路。利用转录组测序鉴定PTPRZ1-Ctrl GSCs和PTPRZ1-KO GSCs组中差异表达基因并通过RT-qPCR和Western blot验证。

结果

与NSTCs比较，GSCs抵抗TAM吞噬的能力较强(

＜0.05)且特异性高表达PTPRZ1。PTPRZ1-KO GSCs抵抗TAM吞噬的能力显著下降(

＜0.01)。高表达PTPRZ1的GBM样本中吞噬相关通路活化显著受抑(

＜0.05)。PTPRZ1-KO GSCs显著下调M2型TAM极化相关趋化因子CCL20的表达(

＜0.05)。CCL20重组蛋白诱导M2型TAM标记物CD163表达升高。

结论

PTPRZ1高表达GSCs介导TAM向M2型极化并抑制其吞噬能力，机制可能与PTPRZ1高表达GSCs上调CCL20表达有关。

Abstract

Objective

To explore the effect of glioma stem cells with high expression of protein tyrosin phosphatase receptor type Z1 (PTPRZ1)on the phenotypic polarization and phagocytosis of tumor-associated macrophages and its regulatory mechanism.

Methods

GSCs and non-stem tumor cells (NSTCs) were screened out from human glioblastoma (GBM) specimens using flow cytometry

and the PTPRZ1 expression in paired GSCs and NSTCs were detected. Human peripheral blood mononuclear cells (PBMC)-derived CD14

monocytes were exposed to the conditioned medium from glioma cells or recombinant chemokine C-C motif ligand 20 (CCL20) for TAM polarization. Stable PTPRZ1 knockout GSCs (PTPRZ1-KO GSCs) were constructed using CRISPR/Cas9. TAM phagocytosis to GSCs

NSTCs

PTPRZ1-Control GSCs (PTPRZ1-Ctrl GSCs) and PTPRZ1-KO GSCs and the expression of immunosuppressive phenotype (M2) polarization marker CD163 were examined using flow cytometry. Differentially expressed genes (DEGs) between paired GSCs and NSTCs were dete

rmined using a bulk RNA-sequencing dataset (GSE54791) from Gene Expression Omnibus (GEO). A gene set informing worse outcome of patients with GBM was generated using The Cancer Genome Atlas (TCGA)-GBM cohort. By intersecting the aforementioned gene set with the gene set that encodes for human membrance proteins

the PTPRZ1 gene is obtained. Gene set enrichment analysis (GSEA) was used for pathway enrichment analysis to compare the differentially regulated pathways between GBMs with high or low PTPRZ1 expression. Bulk RNA sequencing

qRT-PCR and Western blotting were used to identify the DEGs between PTPRZ1-KO GSCs and PTPRZ1-Ctrl GSCs.

Results

GSCs were more capable of escaping from TAM phagocytosis than NSTCs (

0.05) and had specifically up-regulated PTPRZ1 expression. PTPRZ1-KO significantly suppressed GSCs escaping from TAM phagocytosis (

0.01). GBMs with high PTPRZ1 expression showed significant inhibition of pathways mediating phagocytosis (

0.05). The expression of CCL20 as a M2 TAM polarization chemokine was significantly down-regulated in PTPRZ1-KO GSCs (

0.05). Treatment with recombinant CCL20 up-regulated the expression of CD163 as a M2 TAM marker in TAM.

Conclusion

PTPRZ1

GSCs mediate M2 TAM polarization and inhibit TAM phagocytosis

which may be related to the up-regulation of CCL20 in PTPRZ1

GSCs.

关键词

Keywords

references

TAN A C, ASHLEY D M, LÓPEZ G Y, et al . Management of glioblastoma: state of the art and future directions[J ] . CA Cancer J Clin, 2020, 70(4): 299-312. DOI: 10.3322/caac.21613.

罗静远, 杨静, 李雪, 等. 2-脱氧葡萄糖修饰共载siPD-L1及替莫唑胺脂质纳米粒的脑靶向性研究[J]. 空军军医大学学报, 2024, 45(1): 73-79. DOI: 10.13276/j.issn.2097-1656.2024.01.015.

LUO J Y, YANG J, LI X, et al . Brain targeting of 2-deoxyglucose modified lipid nanoparticles co-loaded with siPD-L1 and temozolomide[J ] . J Air Force Med Univ, 2024, 45(1): 73-79. DOI: 10.13276/j.issn.2097-1656.2024.01.015.

GISINA A, KHOLODENKO I, KIM Y, et al . Glioma stem cells: novel data obtained by single-cell sequencing[J ] . Int J Mol Sci, 2022, 23(22): 14224. DOI: 10.3390/ijms232214224.

BOYD N H, TRAN A N, BERNSTOCK J D, et al . Glioma stem cells and their roles within the hypoxic tumor microenvironment[J ] . Theranostics, 2021, 11(2): 665-683. DOI: 10.7150/thno.41692.

SHI Y, PING Y F, ZHOU W C, et al . Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth[J ] . Nat Commun, 2017, 8: 15080. DOI: 10.1038/ncomms15080.

YIN W, PING Y F, LI F, et al . A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma[J ] . J Pathol, 2022, 258(2): 121-135. DOI: 10.1002/path.5984.

刘庆, 杨莹, 安乐乐, 等. PTPRZ1单克隆抗体对胶质瘤干细胞自我更新和侵袭的抑制作用[J]. 陆军军医大学学报, 2023, 28(12). DOI: 10.16016/j.2097-0927.202308042.

LIU Q, YANG Y, AN L L, et al . Inhibiting and invasive self-renewal effect of PTPRZ1 monoclonal antibody on glioma stem cells[J ] . J Army Medical University, 2023, 45(24): 2530-2536. DOI: 10.16016/j.2097-0927.202308042.

GANGOSO E, SOUTHGATE B, BRADLEY L, et al . Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion[J ] . Cell, 2021, 184(9): 2454-2470.e26. DOI: 10.1016/j.cell.2021.03.023.

GROVER A, SANSEVIERO E, TIMOSENKO E, et al . Myeloid-derived suppressor cells: a propitious road to clinic[J ] . Cancer Discov, 2021, 11(11): 2693-2706. DOI: 10.1158/2159-8290.CD-21-0764.

WANG G Q, ZHONG K H, WANG Z, et al . Tumor-associated microglia and macrophages in glioblastoma: from basic insights to therapeutic opportunities[J ] . Front Immunol, 2022, 13: 964898. DOI: 10.3389/fimmu.2022.964898.

ZHOU W C, KE S Q, HUANG Z, et al . Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth[J ] . Nat Cell Biol, 2015, 17(2): 170-182. DOI: 10.1038/ncb3090.

TAO W W, CHU C W, ZHOU W C, et al . Dual role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma[J ] . Nat Commun, 2020, 11(1): 3015. DOI: 10.1038/s41467-020-16827-z.

HIPPE A, BRAUN S A, OLÁH P, et al . EGFR/Ras-induced CCL20 production modulates the tumour microenvironment[J ] . Br J Cancer, 2020, 123(6): 942-954. DOI: 10.1038/s41416-020-0943-2.

KADOMOTO S, IZUMI K, MIZOKAMI A. The CCL20-CCR6 axis in cancer progression[J]. Int J Mol Sci, 2020, 21(15): 5186. DOI: 10.3390/ijms21155186.

WANG D, YANG L, YU W N, et al . Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling[J ] . J Immunother Cancer, 2019, 7(1): 215. DOI: 10.1186/s40425-019-0701-2.

XU C C, FAN L N, LIN Y F, et al . Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization[J ] . Gut Microbes, 2021, 13(1): 1980347. DOI: 10.1080/19490976.2021.1980347..

DONG D D, ZHANG G J, YANG J C, et al . The role of iron metabolism in cancer therapy focusing on tumor-associated macrophages[J ] . J Cell Physiol, 2019, 234(6): 8028-8039. DOI: 10.1002/jcp.27569.

OVAIS M, GUO M Y, CHEN C Y. Tailoring nanomaterials for targeting tumor-associated macrophages[J]. Adv Mater, 2019, 31(19): e1808303. DOI: 10.1002/adma.201808303.

VAN VLERKEN-YSLA L E, RIOS-DORIA J, MOYNIHAN J, et al . Abstract 4779: targeting the CCL20-CCR6 axis as a novel opportunity to stimulataneously modulate cancer stem cells and the tumor-immune infiltrate by a dual anti-cancer mechanism[J ] . Cancer Res, 2017, 77(13_Supplement): 4779. DOI: 10.1158/1538-7445.am2017-4779.

郑文静, 张瀚, 霍毅, 等. 巨噬细胞吞噬检查点阻断在抗肿瘤免疫治疗中的应用[J/OL ] . 空军军医大学学报. [2024-03-05 ] . http://kns.cnki.net/kcms/detail/61.1526.R.20240129.1508.004.html http://kns.cnki.net/kcms/detail/61.1526.R.20240129.1508.004.html .

ZHENG W J, ZHANG H, HUO Y, et al . Application of macrophage phagocytic checkpoint blockade in anti-tumor immunotherapy[J ] . J Air Force Med Univ, [2024-03-05 ] . http://kns.cnki.net/kcms/detail/61.1526.R.20240129.1508.004.html http://kns.cnki.net/kcms/detail/61.1526.R.20240129.1508.004.html ..

浏览量

171

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

miR-382-5p通过Akt/mTOR信号通路影响乳腺癌肿瘤相关巨噬细胞极化

RNAi沉默S100A9对U87胶质瘤干细胞增殖和自我更新的影响

自体荧光技术筛选恶性胶质瘤干细胞的优势分析

PGC-1α通过线粒体介导巨噬细胞极化状态的机制研究

阿司匹林对小鼠胶质瘤干细胞增殖及凋亡的体外研究